Mie Grunnet

916 total citations · 1 hit paper
11 papers, 726 citations indexed

About

Mie Grunnet is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Mie Grunnet has authored 11 papers receiving a total of 726 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in Mie Grunnet's work include Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Peptidase Inhibition and Analysis (3 papers). Mie Grunnet is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Peptidase Inhibition and Analysis (3 papers). Mie Grunnet collaborates with scholars based in Denmark, United Kingdom and United States. Mie Grunnet's co-authors include Jens Benn Sørensen, Morten Mau‐Sørensen, Nils Brünner, Lars Henrik Jensen, Ib Jarle Christensen, Ulrik Lassen, Magnus Christian Lydolph, Juan W. Valle, Mairéad G. McNamara and John Bridgewater and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Mie Grunnet

11 papers receiving 711 citations

Hit Papers

Carcinoembryonic antigen (CEA) as tumor marker in lung ca... 2011 2026 2016 2021 2011 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mie Grunnet Denmark 7 318 289 267 128 124 11 726
Dan Ou China 17 239 0.8× 278 1.0× 146 0.5× 139 1.1× 114 0.9× 38 738
Jinlu Shan China 18 436 1.4× 198 0.7× 169 0.6× 148 1.2× 103 0.8× 41 762
Saumil Gandhi United States 16 259 0.8× 358 1.2× 333 1.2× 159 1.2× 93 0.8× 55 1.0k
Kazumasa Minami Japan 15 262 0.8× 321 1.1× 215 0.8× 67 0.5× 131 1.1× 55 758
Norifumi Hattori Japan 16 275 0.9× 306 1.1× 217 0.8× 52 0.4× 103 0.8× 91 889
Dinesh Doval India 10 218 0.7× 200 0.7× 179 0.7× 87 0.7× 115 0.9× 32 514
Nan Dai China 21 760 2.4× 227 0.8× 166 0.6× 115 0.9× 258 2.1× 75 1.1k
Yuanji Xu China 17 377 1.2× 211 0.7× 98 0.4× 130 1.0× 210 1.7× 70 893
Lingyun Xu China 15 281 0.9× 257 0.9× 119 0.4× 239 1.9× 170 1.4× 42 864

Countries citing papers authored by Mie Grunnet

Since Specialization
Citations

This map shows the geographic impact of Mie Grunnet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mie Grunnet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mie Grunnet more than expected).

Fields of papers citing papers by Mie Grunnet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mie Grunnet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mie Grunnet. The network helps show where Mie Grunnet may publish in the future.

Co-authorship network of co-authors of Mie Grunnet

This figure shows the co-authorship network connecting the top 25 collaborators of Mie Grunnet. A scholar is included among the top collaborators of Mie Grunnet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mie Grunnet. Mie Grunnet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
O’Rourke, Colm J., Christian Dehlendorff, Ole Larsen, et al.. (2020). Serum IL6 as a Prognostic Biomarker and IL6R as a Therapeutic Target in Biliary Tract Cancers. Clinical Cancer Research. 26(21). 5655–5667. 21 indexed citations
2.
Langkjer, Sven Tyge, Jeanette Dupont Jensen, Mie Grunnet, et al.. (2019). The NAME Trial: A Direct Comparison of Classical Oral Navelbine Versus Metronomic Navelbine in Metastatic Breast Cancer. Future Oncology. 15(22). 2561–2569. 6 indexed citations
4.
Grunnet, Mie, Ib Jarle Christensen, Ulrik Lassen, et al.. (2015). Decline in CA19-9 during chemotherapy predicts survival in four independent cohorts of patients with inoperable bile duct cancer. European Journal of Cancer. 51(11). 1381–1388. 21 indexed citations
5.
Grunnet, Mie, Dan Calatayud, Nicolai A. Schultz, et al.. (2015). TOP1 gene copy numbers are increased in cancers of the bile duct and pancreas. Scandinavian Journal of Gastroenterology. 50(4). 485–494. 10 indexed citations
6.
Grunnet, Mie & Morten Mau‐Sørensen. (2014). Serum tumor markers in bile duct cancer – a review. Biomarkers. 19(6). 437–443. 31 indexed citations
7.
Grunnet, Mie, Ib Jarle Christensen, Ulrik Lassen, et al.. (2014). Prognostic significance of circulating intact and cleaved forms of urokinase plasminogen activator receptor in inoperable chemotherapy treated cholangiocarcinoma patients. Clinical Biochemistry. 47(7-8). 599–604. 8 indexed citations
8.
Grunnet, Mie, et al.. (2014). A Fatal Case of Primary Basaloid Squamous Cell Carcinoma in the Intrahepatic Bile Ducts. SHILAP Revista de lepidopterología. 2014. 1–6. 1 indexed citations
9.
Grunnet, Mie, Morten Mau‐Sørensen, & Nils Brünner. (2013). Tissue inhibitor of metalloproteinase 1 (TIMP-1) as a biomarker in gastric cancer: a review. Scandinavian Journal of Gastroenterology. 48(8). 899–905. 43 indexed citations
10.
Grunnet, Mie, Lene Bæksgaard, Inga Laursen, Ulrik Lassen, & Morten Mau‐Sørensen. (2012). Using the decline in CA19-9 after the start of chemotherapy to predict survival in patients with inoperable bile duct cancer.. Journal of Clinical Oncology. 30(4_suppl). 287–287. 1 indexed citations
11.
Grunnet, Mie & Jens Benn Sørensen. (2011). Carcinoembryonic antigen (CEA) as tumor marker in lung cancer. Lung Cancer. 76(2). 138–143. 581 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026